The insulin-like growth factor (IGF) pathway is a major fetal and placental growth-promoting pathway modified by DNA methylation of its components such as IGF2 and IGF binding proteins and is associated with fetal overgrowth in GDM [12, 13]. Here, IGF2 is linked to gestational diabetes.